RecallDepth
Class II Ongoing

Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, NDC 63459-910-11, Blister NDC 63459-910-12; (b)10 syringes in 1 CARTON, NDC 63459-910-15, Blister NDC 63459-910-12; (c) 1 syringe in 1 CARTON, NDC 63459-910-17 without safety guard and blister, Rx Only, Manufactured by: UAB Teva Baltics, Vilnius, Lithuania. Distributed by Teva Pharmaceuticals USA, Inc. North Wales PA 19454. Product of Israel.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
January 10, 2025
Posted
February 12, 2025
Recall Number
D-0218-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
34,636 cartons
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit

Distribution

Product was distributed nationwide.

Lot / Code Info

Lot # (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls